(2)
SANTIAGO, CHILE and PARIS, FRANCE / ACCESSWIRE / January 13, 2021 / Protera, an AI-driven startup designing and developing new proteins to enable a wide range of natural and sustainable solutions, announced today it has appointed Dr. Oswaldo da Costa e Silva as Non-Executive Director to its Board. Dr. da Costa e Silva has over 20 years experience working with and advising global agricultural biotech, life sciences and pharma corporations, as well as SMEs and startups, on strategic growth initiatives.
Currently, Dr. da Costa e Silva is the managing director at InnoCres Consultancy, where he advises pharma, nutrition, food and agricultural biotech companies on strategic, innovation-driven business development opportunities. Previously, he spent over six years in leadership roles focusing on human nutrition and research and development at Royal DSM NV, a Dutch multinational specialized in nutrition, health and sustainable living. Prior to that, he worked for over a decade at BASF
DGAP-News: Prote .
DGAP-News: Protera SAS: Protera Strengthens Board with Appointment of Dr. Oswaldo da Costa e Silva as Non-Executive Director
vom 13.01.2021, 08:00 Uhr
Bild: pixabay.com
DGAP-News: Protera SAS / Key word(s): Personnel
Protera SAS: Protera Strengthens Board with Appointment of Dr. Oswaldo da Costa e Silva as Non-Executive Director
13.01.2021 / 08:00
Protera Strengthens Board with Appointment of Dr. Oswaldo da Costa e Silva as Non-Executive Director
SANTIAGO, CHILE and PARIS, FRANCE / ACCESSWIRE / January 13, 2021 / Protera, an AI-driven startup designing and developing new proteins to enable a wide range of natural and sustainable solutions, announced today it has appointed Dr. Oswaldo da Costa e Silva as Non-Executive Director to its Board. Dr. da Costa e Silva has over 20 years experience working with and advising global agricultural biotech, life sciences and pharma corporations, as well as SMEs and startups, on strategic growth initiatives.